Assistance Publique Hopitaux De Paris

The Service de Neurologie at Assistance Publique Hopitaux De Paris is conducting research focused on managing prolonged immune suppression in critically ill patients.

• Evaluating interferon‑gamma therapy to reduce secondary infections in ICU patients
• Assessing safety and immunological outcomes of standardized immunotherapy

This work aims to improve infection prevention strategies and enhance patient recovery in intensive care settings.

Clinical investigations at the neurology department target Spinal Muscular Atrophy, exploring novel treatments for motor function preservation.

• Testing the efficacy of salanersen (BIIB115) in treatment‑naïve and previously treated SMA participants
• Monitoring movement outcomes and safety across a wide age range

The goal is to provide new therapeutic options that can improve quality of life for individuals living with SMA.